Anti-CEACAM5/CEA/CD66e Antibody (Labetuzumab)
Catalog No.
F1498
Anti-CEACAM5/CEA/CD66e Antibody (Labetuzumab)
Featured Products
Labetuzumab is a humanized anti-carcinoembryonic antigen (CEA) monoclonal antibody that inhibits tumor growth and sensitizes human medullary thyroid cancer xenogeneic cells to Dacarbazine chemotherapy.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.48 kDa
Dry ice
219649-07-7
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
CEA-Cide, hMN14, hMN-14
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P06731
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human CEACAM5 His Biotin at 2 ug/mL can bind Anti-CEACAM5/CEA/CD66e Antibody (Labetuzumab)
CEACAM5 / CEA / CD66e
Please avoid freeze-thaw cycles.